Antibiotics and Veterinary Feed Directive: The times, they are a changin' - Dr. Harry Snelson, American Association of Swine Veterinarians, from 2015 Summer Swine Health Seminar, August 22, 2015, Wrightsville Beach, North Carolina, USA.
More presentations at http://www.swinecast.com/2015-boehringer-ingelheim-carolina-swine-health-seminar
Jeff Verzal - Veterinary Feed Directives Are Here: What Have You Done?John Blue
Veterinary Feed Directives Are Here: What Have You Done? - Jeff Verzal, Iowa Department Of Agriculture And Land Stewardship (IDALS), from the 2017 Iowa Pork Congress, January 25-26, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2017-iowa-pork-congress
This presentation was given as the keynote at the Tennessee College of Law's Agriculture Law & Policy Symposium. It covers a myriad of food and agriculture law topics including Veterinary Feed Directive, Waters of the United States, Syngenta Litigation, GMO Labeling, Country of Origin Labeling, Raw Milk, Food Safety Modernization Act, Idaho's Ag Gag Litigation, Cannabis Law, and Farm Bill.
Lawyer's Guide to the Veterinary Feed DirectiveCari Rincker
This presentation was created for the Lawline.com presentation titled "Lawyer's Guide to the Veterinary Feed Directive." The Lawline presentation will be on November 3, 2016 at 3:30pm ET. The recording of the lecture will subsequently be available via Lawline.com at https://www.lawline.com/faculty/cari-rincker. This presentation is broken up in two parts: (1) General Background discussing definitions, regulatory players and the legal framework, and (2) the Second VFD Rule promulgated in June 2015.
Overview of the Veterinary Feed DirectiveCari Rincker
This presentation was prepared for the 2016 American Agriculture Law Association Annual Educational Symposium. This presentation will be given on October 6, 2016. It first lays the background of the Veterinary Feed Directive ("VFD") and then delves into the requirements of various stakeholders including (1) veterinarians, (2) livestock producers, (3) feed distributors, and (4) drug manufacturers.
Richard Sellers - Changes on Antibiotic Usage - Background, Now, And January 1John Blue
Changes on Antibiotic Usage - Background, Now, And January 1 - Richard Sellers, American Feed Industry Association, from the 2016 World Pork Expo, June 8 - 10, 2016, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2016-world-pork-expo
Dr. Eric Gordon - Discussion on the Veterinary Feed Directive Integration in ...John Blue
Discussion on the Veterinary Feed Directive Integration in Small Ruminant - Dr. Eric Gordon, The Ohio State University, from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Dr. Patricia S. Gaunt - Discussion on the Veterinary Feed Directive Integrati...John Blue
Discussion on the Veterinary Feed Directive Integration in Aquaculture - Dr. Patricia S. Gaunt, Mississippi State University, from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Jeff Verzal - Veterinary Feed Directives Are Here: What Have You Done?John Blue
Veterinary Feed Directives Are Here: What Have You Done? - Jeff Verzal, Iowa Department Of Agriculture And Land Stewardship (IDALS), from the 2017 Iowa Pork Congress, January 25-26, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2017-iowa-pork-congress
This presentation was given as the keynote at the Tennessee College of Law's Agriculture Law & Policy Symposium. It covers a myriad of food and agriculture law topics including Veterinary Feed Directive, Waters of the United States, Syngenta Litigation, GMO Labeling, Country of Origin Labeling, Raw Milk, Food Safety Modernization Act, Idaho's Ag Gag Litigation, Cannabis Law, and Farm Bill.
Lawyer's Guide to the Veterinary Feed DirectiveCari Rincker
This presentation was created for the Lawline.com presentation titled "Lawyer's Guide to the Veterinary Feed Directive." The Lawline presentation will be on November 3, 2016 at 3:30pm ET. The recording of the lecture will subsequently be available via Lawline.com at https://www.lawline.com/faculty/cari-rincker. This presentation is broken up in two parts: (1) General Background discussing definitions, regulatory players and the legal framework, and (2) the Second VFD Rule promulgated in June 2015.
Overview of the Veterinary Feed DirectiveCari Rincker
This presentation was prepared for the 2016 American Agriculture Law Association Annual Educational Symposium. This presentation will be given on October 6, 2016. It first lays the background of the Veterinary Feed Directive ("VFD") and then delves into the requirements of various stakeholders including (1) veterinarians, (2) livestock producers, (3) feed distributors, and (4) drug manufacturers.
Richard Sellers - Changes on Antibiotic Usage - Background, Now, And January 1John Blue
Changes on Antibiotic Usage - Background, Now, And January 1 - Richard Sellers, American Feed Industry Association, from the 2016 World Pork Expo, June 8 - 10, 2016, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2016-world-pork-expo
Dr. Eric Gordon - Discussion on the Veterinary Feed Directive Integration in ...John Blue
Discussion on the Veterinary Feed Directive Integration in Small Ruminant - Dr. Eric Gordon, The Ohio State University, from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Dr. Patricia S. Gaunt - Discussion on the Veterinary Feed Directive Integrati...John Blue
Discussion on the Veterinary Feed Directive Integration in Aquaculture - Dr. Patricia S. Gaunt, Mississippi State University, from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Dr. Ray Matulka, Director of Toxicology at Burdock Group, presents the hurdles of probiotics when being classified from a regulatory standpoint. Dr. Matulka discusses when a probiotic is considered a food, supplement or drug, as well as a potential path forward for the U.S. FDA to implement a probiotic monograph system for probiotics, similar to Health Canada's system.
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsMichael Swit
Presentation to the Regulatory Affairs Certification (RAC) Review Course, sponsored by the Orange County Regulatory Affairs (OCRA) Discussion Group, on August 2, 2014, in Irvine, CA. See slides 4-58 for Labeling/Advertising Discussion; slide 59 to 72 for Imports/Exports, and 73 to end for Enforcement Actions
Dr. Jennifer Koeman, Dr. Harry Snelson - FDA Antibiotic GuidanceJohn Blue
FDA Antibiotic Guidance - Dr. Jennifer Koeman, National Pork Board; Dr. Harry Snelson, American Association Swine Veterinarians, from the 2015 World Pork Expo, June 3 - 5, 2015, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2015-world-pork-expo
Dr. Jennifer Koeman, National Pork Board; Dr. Harry Snelson, American Association Swine Veterinarians, from the 2015 World Pork Expo, June 3 - 5, 2015, Des Moines, IA, USA.
Dr. Carissa Odland - Veterinary Feed Directive Regulation ChangesJohn Blue
Veterinary Feed Directive Regulation Changes - Dr. Carissa Odland, Pipestone Veterinary Services, from the 2016 Iowa Pork Congress, January 27-28, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2016-iowa-pork-congress
In order to promote the uptake of biosimilars across the U.S., stakeholders must be informed about the basic science of these important medicines. Created out of the Biosimilars Forum's Biosimilars Roundtable (formerly the Biosimilars Forum Stakeholder Workshop group), this two page document incorporates feedback from nearly 40 stakeholder groups, from patient advocacy organizations to physician and payer groups, and presents the basic knowledge that all stakeholders need to know about the safety and efficacy of biosimilars, including answers to common myths about them.
Dialogue with Canada’s leading regulatory and assessment experts: Health Canada Bureau of Biologics and Genetic Therapies (BGTD) and Canadian Agency for Drugs and Technologies in Health (CADTH)
Date: June 29, 2016
Time: 1:00pm to 3:00pm EST
February 7, 2017
Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product.
This panel of experts discussed the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective. Topics included how the next generation of biosimilars could improve patient access to standard-of-care therapies, the concept of “biobetters,” economic and intellectual property considerations, and policy approaches to support existing and future biosimilars.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/looking-forward
Hope S. Rugo, MD, FASCO, prepared useful Practice Aids pertaining to biosimilars for this CME/MOC/CNE/CPE activity titled "Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care." For the full presentation, monograph, complete CME/MOC/CNE/CPE information, and to apply for credit, please visit us at http://bit.ly/38DBgFb. CME/MOC/CNE/CPE credit will be available until April 27, 2021.
A generic medicine contains the same active ingredient as the originators product on which it is based and as such is interchangeable with this originators. It offers the same high quality and efficacy, together with affordability. In theory, dosage, indications, cons-indications, side effects and safety guarantees are the same.
The concept of a “similar biological medicinal product” was adopted in EU pharmaceutical legislation in 2004 and came into effect in 2005. The first biosimilar medicine was approved by the European Commission in 2006.
Biologics (eg, vaccines, blood and blood components, somatic cells, gene therapy, tissues, therapeutic proteins) are regulated by the US Food and Drug Administration (FDA). Biologics/Biosimilars/Biobetters are widely used to diagnose, prevent, treat, and cure diseases and medical conditions.
Naveen Kumar Singh received his B.Sc. in Biotechnology (2007) at University of Pune (Pune, India), M.Sc. in Biotechnology (2009) at Jaipur National University (Jaipur, India), and Ph.D. in Biochemical Engineering (2016) at Jacobs University Bremen (Bremen, Germany).
During his Ph.D., Naveen worked under the supervision of Prof. Marcelo Fernández-Lahore. His research dealt with designing experiments for developing fiber-based and cryogel-based adsorbents for capturing large therapeutic biomolecules (proteins, plasmids, and monoclonal antibodies). He had successfully evaluated the in-house fiber- and cryogel-based chromatographic adsorbents with the commercially available adsorbents and the in-house adsorbents had shown similar or higher productivities compared to the commercial adsorbents.
In February 2017, Naveen joined the group of Prof. Merlin L. Bruening in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame as a Postdoctoral Research Associate. His current research focuses on developing novel bioseparation processes by introducing polyelectrolyte multilayer films onto membranes/monoliths for the purification of biotherapeutics like monoclonal antibodies.
Publications:
N. K. Singh, et al, “Preparation and Characterization of Grafted Cellulosic Fibers and their Applications in Protein Purification“, Sep. Purif. Technol., 143 (2015) pp. 177–183. https://www.sciencedirect.com/science/article/pii/S1383586615000714
N. K. Singh, et al, “Direct Capture of His6-tagged Proteins Using Megaporous Cryogels Developed for Metal-ion Affinity Chromatography“, inAffinity Chromatography (Ed.: S. Reichelt), Spinger, New York, USA, Methods in Molecular Biology, 1286 (2015) pp. 201–212. http://link.springer.com/protocol/10.1007/978-1-4939-2447-9_16
N. K. Singh, et al, “Gamma ray mediated functionalization of monolithic cryogels for macro-biomolecule purification“, N. Biotechnol., 31, Supplement (2014) pp. S127. http://www.sciencedirect.com/science/article/pii/S1871678414019906
N. K. Singh, et al, “High capacity cryogel-type adsorbents for protein purification“, J. Chromatogr. A, 1355 (2014) pp. 143–148. https://www.sciencedirect.com/science/article/pii/S0021967314008899
N. S. Bibi, N. K. Singh, et al, “Synthesis and performance of megaporous immobilized metal-ion affinity cryogels for recombinant protein capture and purification“, J. Chromatogr. A, 1272 (2013) pp. 145–149. https://www.sciencedirect.com/science/article/pii/S0021967312017670
Blog articles:
What are cryogels? https://www.biochemadda.com/cryogels-monolith-ion-exchange-affinity-chromatography/
These slides studies the 2018 report by CDER on New Drug Therapy Approvals. Novel drugs were approved at an all time high of 59 (in contrast to the annual average of 33). Among notable approvals include monoclonal for HIV infection, non-opioid drugs for withdrawal symptoms, marijuana based drugs for seizures, and even contraceptive for women that can be used up to a year.
Dr. Christine Hoang - Legislative/Regulatory Update (Congress activities, reg...John Blue
Legislative/Regulatory Update (Congress activities, regulatory activities, AVMA stance) - Dr. Christine Hoang, Assistant Director, Scientific Activities Division, American Veterinary Medical Association, from the 2013 NIAA Merging Values and Technology conference, April 15-17, 2013, Louisville, KY, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-merging-values-and-technology
Dr. Ray Matulka, Director of Toxicology at Burdock Group, presents the hurdles of probiotics when being classified from a regulatory standpoint. Dr. Matulka discusses when a probiotic is considered a food, supplement or drug, as well as a potential path forward for the U.S. FDA to implement a probiotic monograph system for probiotics, similar to Health Canada's system.
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsMichael Swit
Presentation to the Regulatory Affairs Certification (RAC) Review Course, sponsored by the Orange County Regulatory Affairs (OCRA) Discussion Group, on August 2, 2014, in Irvine, CA. See slides 4-58 for Labeling/Advertising Discussion; slide 59 to 72 for Imports/Exports, and 73 to end for Enforcement Actions
Dr. Jennifer Koeman, Dr. Harry Snelson - FDA Antibiotic GuidanceJohn Blue
FDA Antibiotic Guidance - Dr. Jennifer Koeman, National Pork Board; Dr. Harry Snelson, American Association Swine Veterinarians, from the 2015 World Pork Expo, June 3 - 5, 2015, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2015-world-pork-expo
Dr. Jennifer Koeman, National Pork Board; Dr. Harry Snelson, American Association Swine Veterinarians, from the 2015 World Pork Expo, June 3 - 5, 2015, Des Moines, IA, USA.
Dr. Carissa Odland - Veterinary Feed Directive Regulation ChangesJohn Blue
Veterinary Feed Directive Regulation Changes - Dr. Carissa Odland, Pipestone Veterinary Services, from the 2016 Iowa Pork Congress, January 27-28, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2016-iowa-pork-congress
In order to promote the uptake of biosimilars across the U.S., stakeholders must be informed about the basic science of these important medicines. Created out of the Biosimilars Forum's Biosimilars Roundtable (formerly the Biosimilars Forum Stakeholder Workshop group), this two page document incorporates feedback from nearly 40 stakeholder groups, from patient advocacy organizations to physician and payer groups, and presents the basic knowledge that all stakeholders need to know about the safety and efficacy of biosimilars, including answers to common myths about them.
Dialogue with Canada’s leading regulatory and assessment experts: Health Canada Bureau of Biologics and Genetic Therapies (BGTD) and Canadian Agency for Drugs and Technologies in Health (CADTH)
Date: June 29, 2016
Time: 1:00pm to 3:00pm EST
February 7, 2017
Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product.
This panel of experts discussed the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective. Topics included how the next generation of biosimilars could improve patient access to standard-of-care therapies, the concept of “biobetters,” economic and intellectual property considerations, and policy approaches to support existing and future biosimilars.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/looking-forward
Hope S. Rugo, MD, FASCO, prepared useful Practice Aids pertaining to biosimilars for this CME/MOC/CNE/CPE activity titled "Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care." For the full presentation, monograph, complete CME/MOC/CNE/CPE information, and to apply for credit, please visit us at http://bit.ly/38DBgFb. CME/MOC/CNE/CPE credit will be available until April 27, 2021.
A generic medicine contains the same active ingredient as the originators product on which it is based and as such is interchangeable with this originators. It offers the same high quality and efficacy, together with affordability. In theory, dosage, indications, cons-indications, side effects and safety guarantees are the same.
The concept of a “similar biological medicinal product” was adopted in EU pharmaceutical legislation in 2004 and came into effect in 2005. The first biosimilar medicine was approved by the European Commission in 2006.
Biologics (eg, vaccines, blood and blood components, somatic cells, gene therapy, tissues, therapeutic proteins) are regulated by the US Food and Drug Administration (FDA). Biologics/Biosimilars/Biobetters are widely used to diagnose, prevent, treat, and cure diseases and medical conditions.
Naveen Kumar Singh received his B.Sc. in Biotechnology (2007) at University of Pune (Pune, India), M.Sc. in Biotechnology (2009) at Jaipur National University (Jaipur, India), and Ph.D. in Biochemical Engineering (2016) at Jacobs University Bremen (Bremen, Germany).
During his Ph.D., Naveen worked under the supervision of Prof. Marcelo Fernández-Lahore. His research dealt with designing experiments for developing fiber-based and cryogel-based adsorbents for capturing large therapeutic biomolecules (proteins, plasmids, and monoclonal antibodies). He had successfully evaluated the in-house fiber- and cryogel-based chromatographic adsorbents with the commercially available adsorbents and the in-house adsorbents had shown similar or higher productivities compared to the commercial adsorbents.
In February 2017, Naveen joined the group of Prof. Merlin L. Bruening in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame as a Postdoctoral Research Associate. His current research focuses on developing novel bioseparation processes by introducing polyelectrolyte multilayer films onto membranes/monoliths for the purification of biotherapeutics like monoclonal antibodies.
Publications:
N. K. Singh, et al, “Preparation and Characterization of Grafted Cellulosic Fibers and their Applications in Protein Purification“, Sep. Purif. Technol., 143 (2015) pp. 177–183. https://www.sciencedirect.com/science/article/pii/S1383586615000714
N. K. Singh, et al, “Direct Capture of His6-tagged Proteins Using Megaporous Cryogels Developed for Metal-ion Affinity Chromatography“, inAffinity Chromatography (Ed.: S. Reichelt), Spinger, New York, USA, Methods in Molecular Biology, 1286 (2015) pp. 201–212. http://link.springer.com/protocol/10.1007/978-1-4939-2447-9_16
N. K. Singh, et al, “Gamma ray mediated functionalization of monolithic cryogels for macro-biomolecule purification“, N. Biotechnol., 31, Supplement (2014) pp. S127. http://www.sciencedirect.com/science/article/pii/S1871678414019906
N. K. Singh, et al, “High capacity cryogel-type adsorbents for protein purification“, J. Chromatogr. A, 1355 (2014) pp. 143–148. https://www.sciencedirect.com/science/article/pii/S0021967314008899
N. S. Bibi, N. K. Singh, et al, “Synthesis and performance of megaporous immobilized metal-ion affinity cryogels for recombinant protein capture and purification“, J. Chromatogr. A, 1272 (2013) pp. 145–149. https://www.sciencedirect.com/science/article/pii/S0021967312017670
Blog articles:
What are cryogels? https://www.biochemadda.com/cryogels-monolith-ion-exchange-affinity-chromatography/
These slides studies the 2018 report by CDER on New Drug Therapy Approvals. Novel drugs were approved at an all time high of 59 (in contrast to the annual average of 33). Among notable approvals include monoclonal for HIV infection, non-opioid drugs for withdrawal symptoms, marijuana based drugs for seizures, and even contraceptive for women that can be used up to a year.
Dr. Christine Hoang - Legislative/Regulatory Update (Congress activities, reg...John Blue
Legislative/Regulatory Update (Congress activities, regulatory activities, AVMA stance) - Dr. Christine Hoang, Assistant Director, Scientific Activities Division, American Veterinary Medical Association, from the 2013 NIAA Merging Values and Technology conference, April 15-17, 2013, Louisville, KY, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-merging-values-and-technology
Dr. Liz Wagstrom - The Future of Antibiotic Use in Pork ProductionJohn Blue
The Future of Antibiotic Use in Pork Production - Dr. Liz Wagstrom, DVM, Chief Veterinarian, National Pork Producers Council, Washington, D.C., from the 2013 Minnesota Pork Congress, January 16-17, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2013-minnesota-pork-congress
Antibiotic Update - Dr. Dave Pyburn, National Pork Board, from the 2016 Missouri Pork Expo, February 9-10, 2016, Columbia, Missouri, USA.
More presentations at http://www.swinecast.com/2016-missouri-pork-expo
Dr. Michael Murphy - Medically Important Antimicrobials in Animal AgricultureJohn Blue
Medically Important Antimicrobials in Animal Agriculture - Dr. Michael Murphy, Veterinary Medical Officer, Center for Veterinary Medicine (CVM), FDA, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Dr. Matt Anderson - Antibiotic use and future records necessary to keep the g...John Blue
Antibiotic use and future records necessary to keep the government and our customers happy - Dr. Matt Anderson, from the 2012 Allen D. Leman Swine Conference, September 15-18, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2012-leman-swine-conference-material
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
Dr. Annette Jones - Antimicrobial Legislation in CA: Process, Challenges, and...John Blue
Antimicrobial Legislation in CA: Process, Challenges, and Successes - Dr. Annette Jones, State Veterinarian, California Department of Food and Agriculture, from the 2016 NIAA Annual Conference: From Farm to Table - Food System Biosecurity for Animal Agriculture, April 4-7, 2016, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2016_niaa_farm_table_food_system_biosecurity
Mr. Gary Huddleston - Biosecurity in Feed Manufacturing / VFD Update: A Persp...John Blue
Biosecurity in Feed Manufacturing / VFD Update: A Perspective from the Feed Industry - Mr. Gary Huddleston, Manager, Feed Manufacturing Safety & Environmental Affairs, American Feed Industry Association, from the 2016 NIAA Annual Conference: From Farm to Table - Food System Biosecurity for Animal Agriculture, April 4-7, 2016, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2016_niaa_farm_table_food_system_biosecurity
Dr. Chris Rademacher - Veterinary Feed Directive - PORK AcademyJohn Blue
Veterinary Feed Directive - PORK Academy - Dr. Chris Rademacher, Iowa State University, from the 2017 World Pork Expo, June 7 - 9, 2017, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2017-world-pork-expo
Dr. Annette Jones - Complying with California's Senate Bill 27 on Antibiotic ...John Blue
Complying with California's Senate Bill 27 on Antibiotic Use in Livestock - Dr. Annette Jones, State Veterinarian and Director, Animal Health and Food Safety Services, California Department of Food and Agriculture, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Dr. Patrick Gorden - Animal Medicinal Drug Use Clarification Act (AMDUCA)John Blue
Animal Medicinal Drug Use Clarification Act (AMDUCA) - Dr. Patrick Gorden, College of Veterinary Medicine, Iowa State University, from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Dr. Larry Granger - USDA Antimicrobial Resistance Strategy - Farm Foundation ...John Blue
USDA Antimicrobial Resistance Strategy - Farm Foundation Results - Dr. Larry Granger, Antimicrobial Resistance Program; Animal and Plant Health Inspection Service, Veterinary Services; U.S. Department of Agriculture (USDA), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
Dr. Liz Wagstrom - Multiple challenges to antibiotic useJohn Blue
Multiple challenges to antibiotic use - Dr. Liz Wagstrom, from the 2012 Allen D. Leman Swine Conference, September 15-18, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2012-leman-swine-conference-material
Dr. Chris Rademacher - Veterinary Feed Directives Are Here: What Have You Done?John Blue
Veterinary Feed Directives Are Here: What Have You Done? - Dr. Chris Rademacher, Iowa State University, from the 2017 Iowa Pork Congress, January 25-26, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2017-iowa-pork-congress
Similar to Dr. Harry Snelson - Antibiotics and Veterinary Feed Directive: The times, they are a changin' (20)
Jordan Hoewischer - OACI Farmer Certification ProgramJohn Blue
OACI Farmer Certification Program - Jordan Hoewischer, Ohio Farm Bureau, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Fred Yoder - No-till and Climate Change: Fact, Fiction, and IgnoranceJohn Blue
No-till and Climate Change: Fact, Fiction, and Ignorance - Fred Yoder, Former President, National Corn Growers Association, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. John Grove - Fifty Years Of No-till Research In KentuckyJohn Blue
Fifty Years Of No-till Research In Kentucky - Dr. John Grove, Univerity of Kentucky, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Warren Dick - Pioneering No-till Research Since 1962John Blue
Pioneering No-till Research Since 1962 - Dr. Warren Dick, OSU-OARDC (retired), from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Christine Sprunger - The role that roots play in building soil organic ma...John Blue
The role that roots play in building soil organic matter and soil health - Dr. Christine Sprunger, OSU - SENR, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...John Blue
Stratification, the Role of Roots, and Yield Trends after 60 years of No-till - Dr. Leonardo Deiss, OSU, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Steve Culman - No-Till Yield Data AnalysisJohn Blue
No-Till Yield Data Analysis - Dr. Steve Culman, OSU Soil Fertility Extension Specialist, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs John Blue
Soil biological Response to BMPs - Alan Sundermeier, OSU Extension, and Dr. Vinayak Shedekar, USDA-ARS, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Curtis Young - Attracting And Protecting PollinatorsJohn Blue
Attracting And Protecting Pollinators - Dr. Curtis Young, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Sarah Noggle - Cover Crop Decision Tool SelectorJohn Blue
Cover Crop Decision Tool Selector - Sarah Noggle, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Hemp Regulations - Jim Belt, ODA, Head of Hemp for Ohio, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
John Barker - UAVs: Where Are We And What's NextJohn Blue
UAVs: Where Are We And What's Next - John Barker, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Rajbir Bajwa - Medical uses of MarijuanaJohn Blue
Medical uses of Marijuana - Dr. Rajbir Bajwa, Coordinator of legal medical marijuana sales, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...John Blue
Setting up a Corn and Soybean Herbicide Program with Cover Crops - Dr. Jeff Stachler, OSU Extension, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...John Blue
Developing A New Approach To Soil Phosphorus Testing And Recommendations - Dr. Chad Penn, USDA-ARS, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Jim Hoorman - Dealing with Cover Crops after Preventative PlantingJohn Blue
Dealing with Cover Crops after Preventative Planting - Jim Hoorman, Hoorman Soil Health Services, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction John Blue
Dealing with Poor Soil Structure and Soil Compaction - Dr. Sjoerd Duiker, Extension Agronomist, Penn State University, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Christine Brown - Canadian Livestock Producers Efforts to Improve Water QualityJohn Blue
Canadian Livestock Producers Efforts to Improve Water Quality - Christine Brown, Ontario Ministry of Agriculture, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...John Blue
Details Matter (includes details about soil, equipment, cover crops...) - Dr. Lee Briese, North Dakota, 2017 International Crop Adviser of the Year, from the 2020 Conservation Tillage and Technology Conference, held March 3-4, 2020, Ada, OH, USA.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
2. Antibiotic Regulation
US Food and Drug Administration
regulates animal and human
antibiotics
◦ OTC
◦ RX
◦ VFD
State pharmacy boards have authority
over veterinary prescribing
3. Veterinary Feed Directive
Implemented in 1996
Provides for veterinary oversight
without requiring a prescription
3 swine products
◦ Nuflor
◦ Pulmotil
◦ Avilamycin
4. Antibiotic Label Claims
Disease Treatment
Disease Control
Disease Prevention
◦ Treatment, Control and Prevention are
considered therapeutic
◦ FDA has said they are necessary for
animal health and welfare
Growth Promotion or Improvement of
Nutritional Efficiency
5. Antibiotic Classes
Medically important (as defined by
FDA)
◦ Same, or in same classes, as antibiotics
used to treat humans
◦ Most antibiotics approved for use in
animal feed are medically important with
possible exceptions:
Swine: bacitracin, mecadox, narasin,
bambermycin, and tiamulin
6. Guidance for Industry #209
“Production uses” (growth promotion and
nutritional efficiency) of antibiotics in
classes used in human medicine are
injudicious
◦ Does not call them unsafe
Requires other uses of these same
classes of antibiotics be under
“veterinary oversight”
“Voluntarily” working with sponsors to
discontinue claims or migrate production
claims to disease prevention
◦ Guidance #213 gives roadmap on
7. Veterinary Feed Directive
Current requirements
◦ Written for amount of feed to be
consumed in a time period
◦ Original copy required to the feed mill
within 5 days
◦ VCPR
◦ Refills not straightforward
◦ Keep records (mill, veterinarian, farmer)
for two years
8. FDA medically important
All swine antibiotics will be affected
under Guidance 209 except
◦ Bacitracin
◦ Carbadox
◦ Bambermycin
◦ Ionophores
◦ Tiamulin
These antibiotics will remain
available for growth promotion
and/or over-the-counter (OTC) in
feed and water
9. Veterinary Feed Directive
VFD final rule will go into effect in
October, 2015
Growth Promotion and Nutritional
Efficiency Labels will be removed by
Dec. 2016
◦ “Medically Important”
Disease Prevention, Control and
Treatment will be VFD in feed, Rx in
water
10. Guidance for Industry
What does it really mean?
◦ Most growth promotion uses will end by
December 2016
◦ Most feed grade antibiotics will no longer
be available over-the-counter but will
require a veterinary “order”
◦ Antibiotics in water will require a
prescription
11. What does this really mean?
Significant regulatory step that will
result in changes on how antibiotics
are used on the farm
Once those labels are changed, it will
be illegal to utilize these antibiotics to
promote growth
Producers will need a VFD or
prescription to use these products in
feed and water
12. How will this affect pork
producers?
Producers are going to lose some
antibiotics, or uses of antibiotics
Potentially increased costs and
increased time
Producers will need a close
relationship with their veterinarian
14. Veterinary Responsibilities
Must be licensed;
operating in the course of practice and
in compliance;
must write VFD orders in the context
of a VCPR;
15. VFD proposed final rule
VCPR – minimum requirements:
◦ the veterinarian engage with the client to
assume responsibility for making clinical
judgments about patient health,
◦ have sufficient knowledge of the patient
by virtue of patient examination and/or
visits to the facility where the patient is
managed, and
◦ provide for any necessary follow-up
evaluation or care.
16. Veterinary Responsibilities
(con’t)
must only issue a VFD that is in
compliance with approved use;
must prepare a written (nonverbal)
VFD including the veterinarian’s
signature;
VFD includes all required information;
17. Information Required on VFD
• The veterinarian’s name, address,
and telephone number;
• the client’s name, business or home
address, and telephone number;
• the premises at which the animals
specified in the VFD are located;
• the date of VFD issuance;
• the expiration date of the VFD;
• the name of the VFD drug(s);
• the species and production class of
animals to be fed the VFD feed;
• the approximate number of animals
to be fed the VFD feed by the
expiration date of the VFD;
• the indication for which the VFD is
issued;
• the level of VFD drug in the feed
and duration of use;
• the withdrawal time, special
instructions, and cautionary
statements necessary for use of the
drug in conformance with the
approval;
• the number of reorders (refills)
authorized, if permitted by the drug
approval, conditional approval, or
index listing;
• the statement: “Use of feed
containing this veterinary feed
directive (VFD) drug in a manner
other than as directed on the labeling
(extralabel use), is not permitted”;
• an affirmation of intent for
combination VFD drugs as described
in 21 CFR 558.6(b)(6); and
• the veterinarian’s electronic or
written signature.
18. Veterinary Responsibilities
(con’t)
must include certain drug-specific information for each
VFD drug when authorizing drug combinations that
includes more than one VFD drug;
VFD + OTC drugs, must include on the VFD order an
affirmation of intent either to restrict authorized use only
to the VFD drug cited on the VFD or to allow the use of
the cited VFD drug in an approved combination with
one or more OTC drug(s);
must provide the distributor and client with a copy of the
VFD order;
all must retain the original VFD for 2 years; and
must provide VFD orders for inspection and copying by
FDA upon request